A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain

Author： Ripa Steven R   McCarberg Bill H   Munera Catherine   Wen Warren   Landau Craig J  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.9, 2012-06, pp. : 1229-1241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Guide to Its Use in Chronic Non-Malignant Pain

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

CNS Drugs, Vol. 26, Iss. 4, 2012-04 ,pp. : 367-373

Adis International

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Review of its Use in the Management of Chronic Non-Malignant Pain

By Plosker Greg L.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2491-2509

Adis International

Access to resources Recommend Favorite

Effect of Proton Pump Inhibitors on Gastric Juice Volume, Gastric pH and Gastric Intramucosal pH in Critically Ill Patients: A Randomized, Double-Blind, Placebo-Controlled Study

By Gursoy Olcay  

Clinical Drug Investigation, Vol. 28, Iss. 12, 2008-01 ,pp. : 777-782

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Celecoxib versus Naproxen in Patients with Osteoarthritis of the Knee: a Randomized, Double-blind, Double-dummy Trial

By Essex MN   Bhadra P   Sands GH  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1357-1370

Field House Publishing

Access to resources Recommend Favorite

Efficacy and Tolerability Comparison of Ebastine 10 and 20mg with Loratadine 10mg: A Double-Blind, Randomised Study in Patients with Perennial Allergic Rhinitis

By Davies R.J.  

Clinical Drug Investigation, Vol. 16, Iss. 6, 1998-12 ,pp. : 413-420

Adis International

Access to resources Recommend Favorite